University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
UCSF Cancer Biologist Awarded $1 Million Grant From Prostate Cancer Foundation

UCSF Cancer Biologist Awarded $1 Million Grant From Prostate Cancer Foundation

March 16, 2020

In January, Hao Nguyen, MD, PhD, was awarded a $1 million Challenge Award from the Prostate Cancer Foundation (PCF). Nguyen, 44, who holds the Goldberg-Benioff Endowed Professorship in Cancer Biology and is associate professor in UCSF’s Department of Urology, will use the funding over the course ...
Patient Navigators Positively Impact Breast Cancer Patient Care

Patient Navigators Positively Impact Breast Cancer Patient Care

March 13, 2020

Patient navigators are becoming familiar faces in hospitals across the country. They are individuals with professional medical, legal, financial, or administrative experience who act as an advocate and liaison for patients as they maneuver through the often complex healthcare system. Patient navigator programs were first ...
CureTalks Podcast: The Latest in Brain Tumor Treatments and Trials

CureTalks Podcast: The Latest in Brain Tumor Treatments and Trials

March 4, 2020

Our March 2020 CureTalks podcast covered the latest in brain tumor research and treatment with neuro-oncologist Dr. Nancy Bush from UCSF Helen Diller Family Comprehensive Cancer Center.

Peter Carroll, MD, MPH Receives Whitmore Award From Society of Urologic Oncology

Peter Carroll, MD, MPH Receives Whitmore Award From Society of Urologic Oncology

February 21, 2020

In 1993, Society of Urologic Oncology initiated an annual award and lectureship in honor of Dr. Willet Whitmore, who had been involved in early discussions on the formation of the Society and is considered the father of urologic oncology. Peter Carroll, MD, MPH is the recipient ...
New Clinical Trial Targets Mutations Commonly Found in Lower Grade Gliomas

New Clinical Trial Targets Mutations Commonly Found in Lower Grade Gliomas

February 12, 2020

Within the next few months, the UCSF Brain Tumor Center will begin recruiting for a multi-center clinical trial to evaluate AG-881, a small molecule drug, for treatment of residual or recurrent IDH-mutant grade II glioma.  AG-881 is a drug that inhibits the mutated forms of ...
A Dedicated Past, a Promising Future: Cancer Symposium Shines Spotlight on ZSFG Excellence

A Dedicated Past, a Promising Future: Cancer Symposium Shines Spotlight on ZSFG Excellence

February 12, 2020

Even with more than 125 years of caring for San Francisco residents, the faculty and staff at the Zuckerberg San Francisco General (ZSFG) and UCSF find that some issues need more than time to resolve. In this case, it’s the inequities and barriers to care ...